<?xml version="1.0" encoding="UTF-8"?>
<GaPExchange xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="dbGaPEx2.1.5.xsd">

<MetaVariables>
	<Submitter/>
	<Method/>
</MetaVariables>
<MetaLinks/>

<Projects>
	<Project/>
</Projects>

<Studies>

<Study source="dbGaP" accession="phs000240.v1.p1" parentStudy="phs000240.v1.p1" createDate="2010-02-23" modDate="2011-08-03">

<Configuration>
	<Data_Provider><![CDATA[
		<table border="1">
		<tr><th>Title</th><th>Name</th><th>Institute</th></tr>
		<tr><td>Principal Investigator</td><td>John Fingert, MD, PhD</td><td>Department of Ophthalmology and Visual Sciences, Carver College of Medicine, University of Iowa, IA, USA</td></tr>
		<tr><td>Co-Investigators</td><td>Jian Huang, PhD</td><td>Department of Statistics and Actuarial Sciences, University of Iowa, IA, USA</td></tr>
		<tr><td>Co-Investigators</td><td>Kai Wang, PhD</td><td>Department of Biostatistics, University of Iowa, IA, USA</td></tr>
		<tr><td>Co-Investigators</td><td>Todd Scheetz, PhD</td><td>Department of Ophthalmology and Visual Sciences, Carver College of Medicine, University of Iowa, IA, USA</td></tr>
		<tr><td>Co-Investigators</td><td>Michael Kass, MD</td><td>Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St. Louis, MO, USA</td></tr>
		</table>
	]]></Data_Provider>
	<StudyNameEntrez>NEI Ocular Hypertension Treatment Study (OHTS)</StudyNameEntrez>
	<StudyNameReportPage>National Eye Institute (NEI) Ocular Hypertension Treatment Study (OHTS)</StudyNameReportPage>
	<StudyTypes>
		<StudyType>Clinical Trial</StudyType>
	</StudyTypes>
	<Description><![CDATA[
<p>The Ocular Hypertension Treatment Study (OHTS) is an National Eye Institute-sponsored multi-center, randomized, 	prospective treatment trial designed to determine whether lowering intraocular pressure (IOP) in individuals with ocular 	hypertension delays or prevents the development of primary open angle glaucoma (POAG). A total of 1,636 individuals with 	ocular hypertension between 40 and 80 years old were enrolled in the study. In addition to ocular hypertension, subjects 	in the OHTS were required to have normal optic nerve appearance as determined by the OHTS Optic Disc Reading Center and 	normal and reliable visual field tests at the time of enrollment by the OHTS Visual Field Reading Center. OHTS subjects 	were randomly assigned to either an observational group which received close observation or a topical medication group    which received medication as needed to achieve a 20% reduction in IOP from their baseline levels. Subjects then were examined at 	regular intervals for optic disc cupping or visual field defects. Other clinical measures were also obtained from OHTS 	subjects including central corneal thickness (CCT) and intraocular pressure. The primary outcome monitored for the OHTS 	was the development of glaucoma in one or both eyes as defined by reproducible visual field abnormality or reproducible 	optic disc deterioration attributed to POAG by the masked OHTS Endpoint Committee. The OHTS study design has been reported in 	detail (Gordon, 1999; PMID: <a href="http://www.ncbi.nlm.nih.gov/pubmed/10326953" target="_blank">10326953</a>).</p> 	<p>The OHTS confirmed that ocular hypertension is a risk factor for developing POAG and showed that lowering IOP reduced 	the risk for developing POAG (Kass, 2002; PMID: <a href="http://www.ncbi.nlm.nih.gov/pubmed/12049574" target="_blank">12049574</a>). 	The OHTS also demonstrated that thin CCT is a significant risk factor for the 	development of POAG (Gordon, 2002; PMID: <a href="http://www.ncbi.nlm.nih.gov/pubmed/12049575" target="_blank">12049575</a>).</p> 	<p>Blood samples were also collected from 1,077 OHTS participants for an ancillary genetics study. DNA was prepared from 	these samples and used in a genome-wide association scan (GWAS) designed to identify genetic factors that control the 	magnitude of quantitative features of glaucoma (baseline IOP, baseline cup-to-disc ratio, and CCT). Genotypes from the 	GWAS and these clinical data (IOP, cup-to-disc ratio, and CCT) have been provided to dbGaP.</p>]]>
	</Description>
	<StudyInEx><![CDATA[
<p><b>Inclusion Criteria:</b> 		<ol> 			<li>IOP between 24 and 32 in one eye and between 21 and 32 in the other eye</li> 			<li>Age 40-80 years inclusively at the time of enrollment</li> 			<li>Normal and reliable Humphrey 30-2 visual fields for both eyes as determined by the OHTS Visual Field Reading Center</li> 			<li>Normal optic discs in both eyes on clinical examination and on stereoscopic photographs as determined by the 			OHTS Optic Disc Reading Center</li> 			<li>Informed consent</li> 		</ol> 	</p> 	<p><b>Exclusion Criteria:</b> 		<ol> 			<li>Best-corrected visual acuity worse than 20/40 in either eye</li> 			<li>Previous intraocular surgery, except for uncomplicated extracapsular cataract extraction with posterior chamber 			intraocular lens implant and no escape of vitreous to the anterior chamber, strabismus, cosmetic eyelid surgery, and 			radial keratotomy.</li> 			<li>A life-threatening or debilitating disease</li> 			<li>Secondary causes of elevated IOP, including ocular and systemic corticosteroid use.</li> 			<li>Angle closure glaucoma or anatomically narrow angles - 75% of the circumference of the angle must be grade 2 or 			more by the Shaffer criteria.</li> 			<li>Other diseases that cause visual field loss or optic disc abnormalities.</li> 			<li>Difference in cup-disc ratios (horizontal by contour) of the 2 eyes &gt; 0.2</li> 			<li>Background diabetic retinopathy, defined as at least 1 microaneurysm seen on direct ophthalmoscopy with dilated 			pupil. Retinal hemorrhage is not an exclusion unless associated with background or proliferative diabetic retinopahthy.</li> 			<li>Inability to visualize or photograph the optic discs</li> 			<li>Pregnant or nursing women as determined by patient self-report and testing.</li> 		</ol> 	</p>]]>
	</StudyInEx>
	<StudyProjects>
		<Project/>
	</StudyProjects>
	<Publications>
		<Publication>
			<Pubmed pmid="10326953"/>
		</Publication>
		<Publication>
			<Pubmed pmid="10980763"/>
		</Publication>
		<Publication>
			<Pubmed pmid="11024416"/>
		</Publication>
		<Publication>
			<Pubmed pmid="11581049"/>
		</Publication>
		<Publication>
			<Pubmed pmid="11755836"/>
		</Publication>
		<Publication>
			<Pubmed pmid="11874743"/>
		</Publication>
		<Publication>
			<Pubmed pmid="12049574"/>
		</Publication>
		<Publication>
			<Pubmed pmid="12049575"/>
		</Publication>
		<Publication>
			<Pubmed pmid="12742841"/>
		</Publication>
		<Publication>
			<Pubmed pmid="14718290"/>
		</Publication>
		<Publication>
			<Pubmed pmid="14962409"/>
		</Publication>
		<Publication>
			<Pubmed pmid="15197055"/>
		</Publication>
		<Publication>
			<Pubmed pmid="15488816"/>
		</Publication>
		<Publication>
			<Pubmed pmid="15531304"/>
		</Publication>
		<Publication>
			<Pubmed pmid="16009857"/>
		</Publication>
		<Publication>
			<Pubmed pmid="16157799"/>
		</Publication>
		<Publication>
			<Pubmed pmid="16157798"/>
		</Publication>
		<Publication>
			<Pubmed pmid="16226544"/>
		</Publication>
		<Publication>
			<Pubmed pmid="16765666"/>
		</Publication>
		<Publication>
			<Pubmed pmid="16936102"/>
		</Publication>
		<Publication>
			<Pubmed pmid="16949445"/>
		</Publication>
		<Publication>
			<Pubmed pmid="17056362"/>
		</Publication>
		<Publication>
			<Pubmed pmid="16996592"/>
		</Publication>
		<Publication>
			<Pubmed pmid="17095090"/>
		</Publication>
		<Publication>
			<Pubmed pmid="17420364"/>
		</Publication>
		<Publication>
			<Pubmed pmid="18091452"/>
		</Publication>
		<Publication>
			<Pubmed pmid="18268230"/>
		</Publication>
		<Publication>
			<Pubmed pmid="18378313"/>
		</Publication>
		<Publication>
			<Pubmed pmid="18474807"/>
		</Publication>
		<Publication>
			<Pubmed pmid="19243824"/>
		</Publication>
		<Publication>
			<Pubmed pmid="20031222"/>
		</Publication>
	</Publications>
	<Diseases>
		<Disease vocab_source="MESH" vocab_term="Ocular Hypertension"/>
		<Disease vocab_source="MESH" vocab_term="Glaucoma, Open-Angle"/>
	</Diseases>
	<Attributions>
		<Header title="Principal Investigator">
			<AttName>John Fingert, MD, PhD</AttName>
			<Institution>Department of Ophthalmology and Visual Sciences, Carver College of Medicine, University of Iowa, IA, USA</Institution>
		</Header>
		<Header title="Co-Investigators">
			<AttName>Jian Huang, PhD</AttName>
			<Institution>Department of Statistics and Actuarial Sciences, University of Iowa, IA, USA</Institution>
		</Header>
		<Header title="Co-Investigators">
			<AttName>Kai Wang, PhD</AttName>
			<Institution>Department of Biostatistics, University of Iowa, IA, USA</Institution>
		</Header>
		<Header title="Co-Investigators">
			<AttName>Todd Scheetz, PhD</AttName>
			<Institution>Department of Ophthalmology and Visual Sciences, Carver College of Medicine, University of Iowa, IA, USA</Institution>
		</Header>
		<Header title="Co-Investigators">
			<AttName>Michael Kass, MD</AttName>
			<Institution>Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St. Louis, MO, USA</Institution>
		</Header>
		<Header title="Co-Investigators">
			<AttName>Mae Gordon, PhD</AttName>
			<Institution>Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St. Louis, MO, USA</Institution>
		</Header>
		<Header title="Funding Source">
			<AttName>R01 EY018825</AttName>
			<Institution>National Eye Institute, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Funding Source">
			<AttName>X01 HG005248</AttName>
			<Institution>National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Funding Source for Genotyping">
			<AttName>HHSN268200782096C. NIH contract &quot;High throughput genotyping for studying the genetic contributions to human disease&quot;</AttName>
			<Institution>National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
	</Attributions>
	<DisplayPublicSummary>yes</DisplayPublicSummary>
	<StudyHistory><![CDATA[
<p> 		<ul> 			<li>February 1994 - Enrollment opens</li> 			<li>October 1996 - Enrollment closes</li> 			<li>June 2002 - Report that topical ocular hypotensive medication delays or prevents the onset of POAG</li> 			<li>June 2002 - Report of baseline factors that predict the onset of POAG</li> 		</ul> 	</p>]]>
	</StudyHistory>
	<ConsentGroups>
		<ConsentGroup groupNum="0" shortName="NRUP" longName="Subjects did not participate in the study, did not complete a consent document and are included only for the pedigree structure and/or genotype controls, such as HapMap subjects."/>
		<ConsentGroup groupNum="1" shortName="GRC" longName="Glaucoma and related conditions"/>
	</ConsentGroups>
</Configuration>

  <AuthorizedAccess>
    <DacInfo ssDacId="0">
      <DacName>NEI</DacName>
      <DacFullName>National Eye Institute</DacFullName>
      <DacEmail>neidac@nei.nih.gov</DacEmail>
      <DacPhone></DacPhone>
      <DacFax>301-402-0528</DacFax>
      <DacUrl>http://grants.nih.gov/grants/gwas</DacUrl>
    </DacInfo>
    <Policy Policy_ID="phs000240.v1.p1_policy" ref_ssDacId="0">
      <DisplayResearchStatement>yes</DisplayResearchStatement>
      <DisplayPublicSummary>yes</DisplayPublicSummary>
      <EmbargoLength>12</EmbargoLength>
      <YearsUntilRenewal>1</YearsUntilRenewal>
      <WeeksCancelRequest>8</WeeksCancelRequest>
      <PdfSupplementReqired>no</PdfSupplementReqired>
      <AcknowledgementText>
        <para>
               http://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=DUC&amp;view_pdf&amp;stacc=phs000240.v1.p1
            </para>
      </AcknowledgementText>
      <DocumentSet>
        <DataUseCertificate Label="Data Use Certificate" FilePath="https://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=DUC&amp;view_pdf&amp;stacc=phs000240.v1.p1" FileName="NEI_OHTS-DUC.pdf"/>
      </DocumentSet>
    </Policy>
    <ConsentGroups>
      <ParticipantSet groupNum-REF="1">
        <ConsentName>Glaucoma and related conditions</ConsentName>
        <ConsentAbbrev>GRC</ConsentAbbrev>
        <UseLimitation>Under the informed consents, the use of data set is limited to research on glaucoma and related conditions only.</UseLimitation>
        <IrbRequired>No</IrbRequired>
      </ParticipantSet>
    </ConsentGroups>
  </AuthorizedAccess>
  <Documents>
    <Document phd="phd003618.1" type="questionnaire" createDate="2011-07-08" modDate="2011-07-14" urlToXml="http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/GetDocumentXml.cgi?document_id=phd003618.1" urlToHtml="http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/document.cgi?study_id=phs000240.v1.p1&amp;phd=3618">
      <OrigName>Baseline-Protocol.pdf</OrigName>
      <DisplayName>OHTS Baseline/Randomization Visit: BR</DisplayName>
      <Description>OHTS Baseline/Randomization Visit: BR</Description>
      <displayStatus>public</displayStatus>
      <xmlStatus>public</xmlStatus>
    </Document>
    <Document phd="phd003619.1" type="questionnaire" createDate="2011-07-08" modDate="2011-07-14" urlToXml="http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/GetDocumentXml.cgi?document_id=phd003619.1" urlToHtml="http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/document.cgi?study_id=phs000240.v1.p1&amp;phd=3619">
      <OrigName>DISC-protocol.pdf</OrigName>
      <DisplayName>Optic Disc Reading Center Quality &amp;amp; Eligibility Form</DisplayName>
      <Description>Optic Disc Reading Center Quality &amp;amp; Eligibility Form</Description>
      <displayStatus>public</displayStatus>
      <xmlStatus>public</xmlStatus>
    </Document>
    <Document phd="phd003620.1" type="questionnaire" createDate="2011-07-08" modDate="2011-07-14" urlToXml="http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/GetDocumentXml.cgi?document_id=phd003620.1" urlToHtml="http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/document.cgi?study_id=phs000240.v1.p1&amp;phd=3620">
      <OrigName>pachymetry-protocol.pdf</OrigName>
      <DisplayName>OHTS Pachymetry Data Collection: PY</DisplayName>
      <Description>OHTS Pachymetry Data Collection: PY</Description>
      <displayStatus>public</displayStatus>
      <xmlStatus>public</xmlStatus>
    </Document>
    <Document phd="phd003621.1" type="questionnaire" createDate="2011-07-08" modDate="2011-07-14" urlToXml="http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/GetDocumentXml.cgi?document_id=phd003621.1" urlToHtml="http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/document.cgi?study_id=phs000240.v1.p1&amp;phd=3621">
      <OrigName>qualifying-protocol.pdf</OrigName>
      <DisplayName>OHTS Qualifying Assessment: QA</DisplayName>
      <Description>OHTS Qualifying Assessment: QA</Description>
      <displayStatus>public</displayStatus>
      <xmlStatus>public</xmlStatus>
    </Document>
  </Documents>

  <Annotations>
    <DocumentPart phd="phd003618.1" sectionId="V6a">
      <phvList>
        <phvRef variableId="160405"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd003618.1" sectionId="V6b">
      <phvList>
        <phvRef variableId="160406"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd003618.1" sectionId="V7a">
      <phvList>
        <phvRef variableId="160405"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd003618.1" sectionId="V7b">
      <phvList>
        <phvRef variableId="160406"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd003618.1" sectionId="V8a">
      <phvList>
        <phvRef variableId="160405"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd003618.1" sectionId="V8b">
      <phvList>
        <phvRef variableId="160406"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd003619.1" sectionId="V8a">
      <phvList>
        <phvRef variableId="160407"/>
        <phvRef variableId="160408"/>
        <phvRef variableId="160409"/>
        <phvRef variableId="160410"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd003620.1" sectionId="V4a1">
      <phvList>
        <phvRef variableId="160403"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd003620.1" sectionId="V4a2">
      <phvList>
        <phvRef variableId="160404"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd003620.1" sectionId="V4b1">
      <phvList>
        <phvRef variableId="160403"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd003620.1" sectionId="V4b2">
      <phvList>
        <phvRef variableId="160404"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd003620.1" sectionId="V4c1">
      <phvList>
        <phvRef variableId="160403"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd003620.1" sectionId="V4c2">
      <phvList>
        <phvRef variableId="160404"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd003620.1" sectionId="V4d1">
      <phvList>
        <phvRef variableId="160403"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd003620.1" sectionId="V4d2">
      <phvList>
        <phvRef variableId="160404"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd003620.1" sectionId="V4e1">
      <phvList>
        <phvRef variableId="160403"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd003620.1" sectionId="V4e2">
      <phvList>
        <phvRef variableId="160404"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd003621.1" sectionId="V1">
      <phvList>
        <phvRef variableId="160401"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd003621.1" sectionId="V2">
      <phvList>
        <phvRef variableId="160402"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd003621.1" sectionId="V5">
      <phvList>
        <phvRef variableId="160400"/>
      </phvList>
    </DocumentPart>
  </Annotations>



</Study>

</Studies>

</GaPExchange>
